Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Mol Psychiatry ; 23(2): 263-270, 2018 02.
Article in English | MEDLINE | ID: mdl-28044064

ABSTRACT

Difficulties in social communication are part of the phenotypic overlap between autism spectrum disorders (ASD) and schizophrenia. Both conditions follow, however, distinct developmental patterns. Symptoms of ASD typically occur during early childhood, whereas most symptoms characteristic of schizophrenia do not appear before early adulthood. We investigated whether overlap in common genetic influences between these clinical conditions and impairments in social communication depends on the developmental stage of the assessed trait. Social communication difficulties were measured in typically-developing youth (Avon Longitudinal Study of Parents and Children, N⩽5553, longitudinal assessments at 8, 11, 14 and 17 years) using the Social Communication Disorder Checklist. Data on clinical ASD (PGC-ASD: 5305 cases, 5305 pseudo-controls; iPSYCH-ASD: 7783 cases, 11 359 controls) and schizophrenia (PGC-SCZ2: 34 241 cases, 45 604 controls, 1235 trios) were either obtained through the Psychiatric Genomics Consortium (PGC) or the Danish iPSYCH project. Overlap in genetic influences between ASD and social communication difficulties during development decreased with age, both in the PGC-ASD and the iPSYCH-ASD sample. Genetic overlap between schizophrenia and social communication difficulties, by contrast, persisted across age, as observed within two independent PGC-SCZ2 subsamples, and showed an increase in magnitude for traits assessed during later adolescence. ASD- and schizophrenia-related polygenic effects were unrelated to each other and changes in trait-disorder links reflect the heterogeneity of genetic factors influencing social communication difficulties during childhood versus later adolescence. Thus, both clinical ASD and schizophrenia share some genetic influences with impairments in social communication, but reveal distinct developmental profiles in their genetic links, consistent with the onset of clinical symptoms.


Subject(s)
Autism Spectrum Disorder/genetics , Schizophrenia/genetics , Verbal Behavior/physiology , Adolescent , Attention Deficit Disorder with Hyperactivity/genetics , Autism Spectrum Disorder/physiopathology , Child , Child Development Disorders, Pervasive/genetics , Communication , Female , Genome-Wide Association Study , Humans , Language , Longitudinal Studies , Male , Multifactorial Inheritance/genetics , Risk Factors , Schizophrenia/physiopathology , Social Behavior
2.
Transl Psychiatry ; 7(1): e1012, 2017 01 24.
Article in English | MEDLINE | ID: mdl-28117840

ABSTRACT

Variants at microRNA-137 (MIR137), one of the most strongly associated schizophrenia risk loci identified to date, have been associated with poorer cognitive performance. As microRNA-137 is known to regulate the expression of ~1900 other genes, including several that are independently associated with schizophrenia, we tested whether this gene set was also associated with variation in cognitive performance. Our analysis was based on an empirically derived list of genes whose expression was altered by manipulation of MIR137 expression. This list was cross-referenced with genome-wide schizophrenia association data to construct individual polygenic scores. We then tested, in a sample of 808 patients and 192 controls, whether these risk scores were associated with altered performance on cognitive functions known to be affected in schizophrenia. A subgroup of healthy participants also underwent functional imaging during memory (n=108) and face processing tasks (n=83). Increased polygenic risk within the empirically derived miR-137 regulated gene score was associated with significantly lower performance on intelligence quotient, working memory and episodic memory. These effects were observed most clearly at a polygenic threshold of P=0.05, although significant results were observed at all three thresholds analyzed. This association was found independently for the gene set as a whole, excluding the schizophrenia-associated MIR137 SNP itself. Analysis of the spatial working memory fMRI task further suggested that increased risk score (thresholded at P=10-5) was significantly associated with increased activation of the right inferior occipital gyrus. In conclusion, these data are consistent with emerging evidence that MIR137 associated risk for schizophrenia may relate to its broader downstream genetic effects.


Subject(s)
Brain/physiopathology , Cognition , Facial Recognition , Memory, Episodic , Memory, Short-Term , MicroRNAs/genetics , Schizophrenia/genetics , Schizophrenic Psychology , Adult , Brain/diagnostic imaging , Case-Control Studies , Female , Functional Neuroimaging , Humans , Magnetic Resonance Imaging , Male , Memory , Middle Aged , Multifactorial Inheritance , Polymorphism, Single Nucleotide , Schizophrenia/physiopathology , Task Performance and Analysis , Young Adult
3.
Mol Psychiatry ; 20(11): 1366-72, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25421404

ABSTRACT

Significant evidence exists for the association between copy number variants (CNVs) and Autism Spectrum Disorder (ASD); however, most of this work has focused solely on the diagnosis of ASD. There is limited understanding of the impact of CNVs on the 'sub-phenotypes' of ASD. The objective of this paper is to evaluate associations between CNVs in differentially brain expressed (DBE) genes or genes previously implicated in ASD/intellectual disability (ASD/ID) and specific sub-phenotypes of ASD. The sample consisted of 1590 cases of European ancestry from the Autism Genome Project (AGP) with a diagnosis of an ASD and at least one rare CNV impacting any gene and a core set of phenotypic measures, including symptom severity, language impairments, seizures, gait disturbances, intelligence quotient (IQ) and adaptive function, as well as paternal and maternal age. Classification analyses using a non-parametric recursive partitioning method (random forests) were employed to define sets of phenotypic characteristics that best classify the CNV-defined groups. There was substantial variation in the classification accuracy of the two sets of genes. The best variables for classification were verbal IQ for the ASD/ID genes, paternal age at birth for the DBE genes and adaptive function for de novo CNVs. CNVs in the ASD/ID list were primarily associated with communication and language domains, whereas CNVs in DBE genes were related to broader manifestations of adaptive function. To our knowledge, this is the first study to examine the associations between sub-phenotypes and CNVs genome-wide in ASD. This work highlights the importance of examining the diverse sub-phenotypic manifestations of CNVs in ASD, including the specific features, comorbid conditions and clinical correlates of ASD that comprise underlying characteristics of the disorder.


Subject(s)
Autism Spectrum Disorder/genetics , Autism Spectrum Disorder/physiopathology , DNA Copy Number Variations/genetics , Genetic Predisposition to Disease/genetics , Phenotype , Adolescent , Adult , Aged , Analysis of Variance , Disabled Children , Female , Humans , Logistic Models , Male , Middle Aged , Parents , Psychiatric Status Rating Scales , Young Adult
4.
Mol Psychiatry ; 19(8): 872-9, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24126926

ABSTRACT

Schizophrenia (SZ) and autism spectrum disorders (ASDs) are complex neurodevelopmental disorders that may share an underlying pathology suggested by shared genetic risk variants. We sequenced the exonic regions of 215 genes in 147 ASD cases, 273 SZ cases and 287 controls, to identify rare risk mutations. Genes were primarily selected for their function in the synapse and were categorized as: (1) Neurexin and Neuroligin Interacting Proteins, (2) Post-synaptic Glutamate Receptor Complexes, (3) Neural Cell Adhesion Molecules, (4) DISC1 and Interactors and (5) Functional and Positional Candidates. Thirty-one novel loss-of-function (LoF) variants that are predicted to severely disrupt protein-coding sequence were detected among 2 861 rare variants. We found an excess of LoF variants in the combined cases compared with controls (P=0.02). This effect was stronger when analysis was limited to singleton LoF variants (P=0.0007) and the excess was present in both SZ (P=0.002) and ASD (P=0.001). As an individual gene category, Neurexin and Neuroligin Interacting Proteins carried an excess of LoF variants in cases compared with controls (P=0.05). A de novo nonsense variant in GRIN2B was identified in an ASD case adding to the growing evidence that this is an important risk gene for the disorder. These data support synapse formation and maintenance as key molecular mechanisms for SZ and ASD.


Subject(s)
Child Development Disorders, Pervasive/genetics , Genetic Predisposition to Disease/genetics , Mutation/genetics , Nerve Tissue Proteins/genetics , Schizophrenia/genetics , Case-Control Studies , Female , Humans , Male , Middle Aged , White People/genetics
5.
Psychol Med ; 44(10): 2177-87, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24284030

ABSTRACT

BACKGROUND: Genetic studies of single gene variants have been criticized as providing a simplistic characterization of the genetic basis of illness risk that ignores the effects of other variants within the same biological pathways. Of candidate biological pathways for schizophrenia (SZ), the cell adhesion molecule (CAM) pathway has repeatedly been linked to both psychosis and neurocognitive dysfunction. Here we tested, using risk allele scores derived from the Schizophrenia Psychiatric Genome-Wide Association Study Consortium (PGC-SCZ), whether alleles within the CAM pathway were correlated with poorer neuropsychological function in patients. METHOD: In total, 424 patients with psychosis were assessed in areas of cognitive ability typically found to be impaired in SZ: intelligence quotient, memory, working memory and attentional control. CAM pathway genes were identified using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Alleles within these genes identified as significantly associated with SZ risk in the PGC-SCZ were then used to calculate a CAM pathway-based polygenic risk allele score for each patient and these scores were tested for association with cognitive ability. RESULTS: Increased CAM pathway polygenic risk scores were significantly associated with poorer performance on measures of memory and attention, explaining 1-3% of variation on these measures. Notably, the most strongly associated single nucleotide polymorphism (SNP) in the CAM pathway (rs9272105 within HLA-DQA1) explained a similar amount of variance in attentional control, but not memory, as the polygenic risk analysis. CONCLUSIONS: These data support a role for the CAM pathway in cognitive function, both at the level of individual SNPs and the wider pathway. In so doing these data highlight the value of pathway-based polygenic risk score studies as well as single gene studies for understanding SZ-associated deficits in cognition.


Subject(s)
Cell Adhesion Molecules/genetics , Cognition Disorders/genetics , Psychotic Disorders/genetics , Schizophrenia/genetics , Signal Transduction/genetics , Adult , Alleles , Cognition Disorders/etiology , Cognition Disorders/physiopathology , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , HLA-DQ alpha-Chains/genetics , Humans , Male , Middle Aged , Multifactorial Inheritance , Psychotic Disorders/complications , Psychotic Disorders/physiopathology , Schizophrenia/complications , Schizophrenia/physiopathology
6.
Child Care Health Dev ; 39(2): 202-12, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22168816

ABSTRACT

OBJECTIVE: We wished to ascertain if there is an association between symptoms of attention-deficit/hyperactivity disorder (ADHD) and home environment in children with ADHD and non-ADHD siblings, controlling for other environmental measures. METHODS: 96 children with ADHD combined type (ADHD-CT) and their siblings participated in the study. Parent and teacher Conners' rating scales were completed and home environment was assessed using the middle childhood and early adolescent Home Observation for Measurement of the Environment (HOME). ADHD symptoms were assessed for correlation with HOME in children with ADHD-CT and non-ADHD siblings and multiple regression analysis was used to control for gender, socio-economic status, exposure to nicotine, exposure to alcohol in utero, birth weight, gestational age, pregnancy and perinatal risk factors. The presence of oppositional disorders was assessed for association with HOME score in those with ADHD-CT. The multiple regression analysis was repeated controlling for environmental factors and for oppositional disorders in those with ADHD-CT. Oppositional symptoms were assessed for correlation with HOME score in non-ADHD siblings. RESULTS: Teacher-rated hyperactive/impulsive scores correlated with HOME (r=-0.27, P < 0.01) in children with ADHD-CT. This association remained significant when other environmental factors and oppositional disorders were controlled for. Environmental factors and gender contributed to 30% of the variance of ADHD symptoms in ADHD-CT. Parent-rated hyperactive/impulsive scores also correlated with HOME (r=-0.28, P < 0.05) for non-ADHD siblings. An association between HOME and diagnosis of oppositional defiant disorder or conduct disorder was found for children with ADHD-CT and between HOME and oppositional symptoms in non-ADHD siblings. CONCLUSIONS: The home environment has a small but significant association with hyperactive/impulsive symptoms in children with ADHD-CT and non-ADHD siblings. This association remained when other environmental factors were taken into account. Oppositional symptoms are associated with home environment in ADHD-CT and in non-ADHD siblings.


Subject(s)
Attention Deficit Disorder with Hyperactivity/etiology , Environment , Family Health , Hyperkinesis/epidemiology , Impulsive Behavior/epidemiology , Siblings/psychology , Adolescent , Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit and Disruptive Behavior Disorders/epidemiology , Attention Deficit and Disruptive Behavior Disorders/etiology , Child , Female , Humans , Male , Psychiatric Status Rating Scales , Risk Factors , Sex Factors , Social Class , Social Environment
7.
Biol Psychol ; 83(2): 159-65, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20018225

ABSTRACT

Cohort studies have considerable prima facie value for investigating epigenetic processes in psychological disorder; however, the future prospects for such studies will depend on valid peripheral markers. The purpose of this pilot study was to investigate association between buccal cell methylation and risk for depression. Epigenotyping was limited to promoter methylation of the serotonin transporter gene (5HTT). A transcription limiting VNTR in the 5HTT promoter (5HTTLPR) was also genotyped. A nested sample of 25 depressed and 125 non-depressed adolescents was drawn from an established longitudinal study of adolescent health. There was no association between depressive symptoms and either buccal cell 5HTT methylation or 5HTTLPR. However, depressive symptoms were more common among those with elevated buccal cell 5HTT methylation who carried 5HTTLPR short-allele (OR 4.9, CI 1.9-13, p=0.001). Both complete and partial (as little as 10%) methylation of a 5HTT reporter gene in an expressing cell line reduced 5HTT activity. Replication is needed.


Subject(s)
Depressive Disorder/genetics , Depressive Disorder/psychology , Serotonin Plasma Membrane Transport Proteins/genetics , Adolescent , Biomarkers , Cohort Studies , Depressive Disorder/diagnosis , Epigenesis, Genetic , Female , Humans , Male , Methylation , Pilot Projects , Risk Factors , Severity of Illness Index , Young Adult
8.
Pharmacogenomics J ; 10(5): 442-7, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20029387

ABSTRACT

Association studies have found that variation in the dopamine transporter gene (SLC6A3) is important in the susceptibility to attention-deficit hyperactivity disorder (ADHD) and response to methylphenidate treatment. An understanding of the biological mechanisms underlying these associations is still inconclusive. We assessed the relative activity of variable number tandem repeat (VNTR) alleles of SLC6A3 under basal and stimulated cellular conditions, as well as in the presence of pharmacological blockade of the dopamine transporter using gene-reporter constructs. The intron 8 VNTR 5-repeat allele is more active than the 6-repeat allele. In the presence of forskolin, both alleles were significantly induced. Blockade of the dopamine transporter did not influence activity of either allelic construct. No difference in activity between 9- and 10-repeat alleles of the 3'-untranslated region VNTR was observed under any experimental condition. These data suggest that the intron 8 VNTR is a functional variant with an ADHD susceptibility allele having reduced activity. The lack of enhanced allele-specific activity in response to treatment regimes suggests that differential activity under basal conditions is the primary mode of action.


Subject(s)
3' Untranslated Regions/genetics , Dopamine Plasma Membrane Transport Proteins/genetics , Introns/genetics , Minisatellite Repeats , Alleles , Attention Deficit Disorder with Hyperactivity/drug therapy , Attention Deficit Disorder with Hyperactivity/genetics , Cell Culture Techniques , Cell Line, Tumor , Colforsin/pharmacology , Dopamine Plasma Membrane Transport Proteins/antagonists & inhibitors , Dopamine Uptake Inhibitors/therapeutic use , Genes, Reporter , Genetic Vectors , Humans , Luciferases/genetics , Methylphenidate/therapeutic use , Piperazines/pharmacology , Transfection
9.
Am J Med Genet B Neuropsychiatr Genet ; 153B(1): 97-102, 2010 Jan 05.
Article in English | MEDLINE | ID: mdl-19388000

ABSTRACT

We [Hawi et al. (2005); Am J Hum Genet 77:958-965] reported paternal over-transmission of risk alleles in some ADHD-associated genes. This was particularly clear in the case of the DAT1 3'-UTR VNTR. In the current investigation, we analyzed three new sample comprising of 1,248 ADHD nuclear families to examine the allelic over-transmission of DAT1 in ADHD. The IMAGE sample, the largest of the three-replication samples, provides strong support for a parent of origin effect for allele 6 and the 10 repeat allele (intron 8 and 3'-UTR VNTR, respectively) of DAT1. In addition, a similar pattern of over-transmission of paternal risk haplotypes (constructed from the above alleles) was also observed. Some support is also derived from the two smaller samples although neither is independently significant. Although the mechanism driving the paternal over-transmission of the DAT risk alleles is not known, these finding provide further support for this phenomenon.


Subject(s)
Alleles , Attention Deficit Disorder with Hyperactivity/genetics , Dopamine Plasma Membrane Transport Proteins/genetics , Genomic Imprinting , Haplotypes , 3' Untranslated Regions , Humans , Minisatellite Repeats
10.
Ir J Med Sci ; 178(2): 193-9, 2009 Jun.
Article in English | MEDLINE | ID: mdl-18651205

ABSTRACT

BACKGROUND: The social communication questionnaire (SCQ) for autistic spectrum disorder was previously validated in clinical populations. AIMS: To describe the distribution of SCQ-scores in the general child population, and identify if traits from all domains of autism are present. METHODS: The SCQ was completed by parents of children attending a mixed-gender primary school of 240 children. RESULTS: Total SCQ scores ranged from 1 to 20, with a mode 1 and corrected mean of 3.89, SD = 2.77. SCQ items corresponding to all three domains of autism were found in the sample. Some items on the SCQ were answered as "autism-positive" for up to 41.8% of children in the general population sample. CONCLUSIONS: The SCQ has a wide range in the general population, with traits from all three domains of autism. Some items in the SCQ do not discriminate children with autism from other school-going children.


Subject(s)
Autistic Disorder/diagnosis , Communication , Interpersonal Relations , Schools/statistics & numerical data , Students/statistics & numerical data , Surveys and Questionnaires , Adolescent , Child , Child Development Disorders, Pervasive/diagnosis , Child, Preschool , Data Collection , Female , Humans , Ireland , Male , Psychometrics , Statistics as Topic
11.
Am J Med Genet B Neuropsychiatr Genet ; 147B(8): 1564-7, 2008 Dec 05.
Article in English | MEDLINE | ID: mdl-18937296

ABSTRACT

Replication is a key to resolving whether a reported genetic association represents a false positive finding or an actual genetic risk factor. In a previous study screening 51 candidate genes for association with ADHD in a multi-centre European sample (the IMAGE project), two single nucleotide polymorphisms (SNPs) within the norepinephrine transporter (SLC6A2) gene were found to be associated with attention deficit hyperactivity disorder (ADHD). The same SNP alleles were also reported to be associated with ADHD in a separate study from the Massachusetts General Hospital in the US. Using two independent samples of ADHD DSM-IV combined subtype trios we attempted to replicate the reported associations with SNPs rs11568324 and rs3785143 in SLC6A2. Significant association of the two markers was not observed in the two independent replication samples. However, across all four datasets the overall evidence of association with ADHD was significant (for SNP rs11568324 P = 0.0001; average odds ratio = 0.33; for SNP rs3785143 P = 0.008; average odds ratio = 1.3). The data were consistent for rs11568324, suggesting the existence of a rare allele conferring protection for ADHD within the SLC6A2 gene. Further investigations should focus on identifying the mechanisms underlying the protective effect.


Subject(s)
Alleles , Attention Deficit Disorder with Hyperactivity/genetics , Genetic Predisposition to Disease , Norepinephrine Plasma Membrane Transport Proteins/genetics , Adolescent , Attention Deficit Disorder with Hyperactivity/diagnosis , Case-Control Studies , Chi-Square Distribution , Child , Child, Preschool , Gene Frequency , Genetic Markers , Genotype , Heterozygote , Humans , Introns , Mothers/statistics & numerical data , Multicenter Studies as Topic , Odds Ratio , Parents , Polymorphism, Single Nucleotide , Siblings
12.
Am J Med Genet B Neuropsychiatr Genet ; 147B(8): 1519-23, 2008 Dec 05.
Article in English | MEDLINE | ID: mdl-18668530

ABSTRACT

Multiple studies have reported an association between attention deficit hyperactivity disorder (ADHD) and the 10-repeat allele of a variable number tandem repeat (VNTR) polymorphism in the 3'-untranslated region (3'UTR) of the dopamine transporter gene (DAT1). Yet, recent meta-analyses of available data find little or no evidence for this association; although there is strong evidence for heterogeneity between datasets. This pattern of findings could arise for several reasons including the presence of relatively rare risk alleles on common haplotype backgrounds or the functional interaction of two or more loci within the gene. We previously described the importance of a specific haplotype at the 3' end of DAT1, as well as the identification of associated single nucleotide polymorphisms (SNPs) within or close to 5' regulatory sequences. In this study we replicate the association of SNPs at the 5' end of the gene and identify a specific risk haplotype spanning the 5' and 3' markers. These findings indicate the presence of at least two loci associated with ADHD within the DAT1 gene and suggest that either additive or interaction effects of these two loci on the risk for ADHD. Overall these data provide further evidence that genetic variants of the dopamine transporter gene confer an increased risk for ADHD.


Subject(s)
5' Untranslated Regions/genetics , Attention Deficit Disorder with Hyperactivity/genetics , Dopamine Plasma Membrane Transport Proteins/genetics , Genetic Heterogeneity , Genetic Variation , Alleles , Attention Deficit Disorder with Hyperactivity/diagnosis , Europe , Gene Frequency , Genetic Markers , Haplotypes , Humans , Linkage Disequilibrium , Microsatellite Repeats , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Risk Factors , White People
13.
Am J Med Genet B Neuropsychiatr Genet ; 147B(7): 1306-9, 2008 Oct 05.
Article in English | MEDLINE | ID: mdl-18452186

ABSTRACT

Several independent studies have reported association between serotonin transporter gene (SLC6A4) polymorphisms and attention deficit hyperactivity disorder (ADHD). Five studies found evidence for association between the long-allele of a 44-bp insertion/deletion polymorphism (5-HTTLPR) and ADHD. Another two studies corroborated this finding while a further six studies did not find such an association. For a second polymorphism within the gene, a variable number tandem repeat (VNTR) within intron 2, one study demonstrated that the 12/12 genotype was significantly less frequent in ADHD cases compared to controls, while a second study found that the 12-allele was preferentially transmitted to offspring affected with ADHD. To provide further clarification of the reported associations, we investigated the association of these two markers with ADHD in a sample of 1,020 families with 1,166 combined type ADHD cases for the International Multi-Centre ADHD Genetics project, using the Transmission Disequilibrium Test. Given the large body of work supporting the association of the promoter polymorphism and mood disorders, we further analyzed the group of subjects with ADHD plus mood disorder separately. No association was found between either of the two markers and ADHD in our large multisite study or with depression within the sample of ADHD cases.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Polymorphism, Genetic/genetics , Serotonin Plasma Membrane Transport Proteins/genetics , Adolescent , Child , Child, Preschool , Depression/genetics , Family Health , Genetic Predisposition to Disease/genetics , Humans , Mood Disorders/genetics
14.
Mol Psychiatry ; 13(5): 514-21, 2008 May.
Article in English | MEDLINE | ID: mdl-18180756

ABSTRACT

As part of the International Multi-centre ADHD Genetics project we completed an affected sibling pair study of 142 narrowly defined Diagnostic and Statistical Manual of Mental Disorders, fourth edition combined type attention deficit hyperactivity disorder (ADHD) proband-sibling pairs. No linkage was observed on the most established ADHD-linked genomic regions of 5p and 17p. We found suggestive linkage signals on chromosomes 9 and 16, respectively, with the highest multipoint nonparametric linkage signal on chromosome 16q23 at 99 cM (log of the odds, LOD=3.1) overlapping data published from the previous UCLA (University of California, Los Angeles) (LOD>1, approximately 95 cM) and Dutch (LOD>1, approximately 100 cM) studies. The second highest peak in this study was on chromosome 9q22 at 90 cM (LOD=2.13); both the previous UCLA and German studies also found some evidence of linkage at almost the same location (UCLA LOD=1.45 at 93 cM; German LOD=0.68 at 100 cM). The overlap of these two main peaks with previous findings suggests that loci linked to ADHD may lie within these regions. Meta-analysis or reanalysis of the raw data of all the available ADHD linkage scan data may help to clarify whether these represent true linked loci.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Chromosomes, Human, Pair 16/genetics , Chromosomes, Human, Pair 9/genetics , Polymorphism, Single Nucleotide , Attention Deficit Disorder with Hyperactivity/epidemiology , Child , Comorbidity , Europe/epidemiology , Europe/ethnology , Female , Genotype , Humans , Israel/epidemiology , Lod Score , Male , Observer Variation , Severity of Illness Index , Siblings , United States/epidemiology , White People/genetics
15.
Genes Brain Behav ; 6(7): 647-52, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17504250

ABSTRACT

We investigated whether a composite genetic factor, based on the combined actions of catechol-O-methyltransferase (COMT) (Val(158)Met) and serotonin transporter (5HTTLPR) (Long-Short) functional loci, has a greater capacity to predict persistence of anxiety across adolescence than either locus in isolation. Analyses were performed on DNA collected from 962 young Australians participating in an eight-wave longitudinal study of mental health and well-being (Victorian Adolescent Health Cohort Study). When the effects of each locus were examined separately, small dose-response reductions in the odds of reporting persisting generalized (free-floating) anxiety across adolescence were observed for the COMT Met(158) [odds ratio (OR) = 0.85, 95% confidence interval (CI) = 0.76-0.95, P = 0.004] and 5HTTLPR Short alleles (OR = 0.88, CI = 0.79-0.99, P = 0.033). There was no evidence for a dose-response interaction effect between loci. However, there was a double-recessive interaction effect in which the odds of reporting persisting generalized anxiety were more than twofold reduced (OR = 0.45, CI = 0.29-0.70, P < 0.001) among carriers homozygous for both the COMT Met(158) and the 5HTTLPR Short alleles (Met(158)Met + Short-Short) compared with the remaining cohort. The double-recessive effect remained after multivariate adjustment for a range of psychosocial predictors of anxiety. Exploratory stratified analyses suggested that genetic protection may be more pronounced under conditions of high stress (insecure attachments and sexual abuse), although strata differences did not reach statistical significance. By describing the interaction between genetic loci, it may be possible to describe composite genetic factors that have a more substantial impact on psychosocial development than individual loci alone, and in doing so, enhance understanding of the contribution of constitutional processes in mental health outcomes.


Subject(s)
Anxiety/epidemiology , Anxiety/genetics , Catechol O-Methyltransferase/genetics , Serotonin Plasma Membrane Transport Proteins/genetics , Adolescent , Adult , Amino Acid Substitution , Anxiety/psychology , Child Abuse, Sexual/psychology , Cohort Studies , DNA/genetics , Female , Gene Frequency , Genotype , Humans , Longitudinal Studies , Male , Methionine/genetics , Methionine/physiology , Models, Genetic , Psychiatric Status Rating Scales , Risk Assessment , Socioeconomic Factors , Surveys and Questionnaires , Valine/genetics , Valine/physiology , Victoria/epidemiology
16.
Mol Psychiatry ; 11(10): 934-53, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16894395

ABSTRACT

Attention deficit hyperactivity disorder (ADHD) is a common neurodevelopmental disorder, starting in early childhood and persisting into adulthood in the majority of cases. Family and twin studies have demonstrated the importance of genetic factors and candidate gene association studies have identified several loci that exert small but significant effects on ADHD. To provide further clarification of reported associations and identify novel associated genes, we examined 1,038 single-nucleotide polymorphisms (SNPs) spanning 51 candidate genes involved in the regulation of neurotransmitter pathways, particularly dopamine, norepinephrine and serotonin pathways, in addition to circadian rhythm genes. Analysis used within family tests of association in a sample of 776 DSM-IV ADHD combined type cases ascertained for the International Multi-centre ADHD Gene project. We found nominal significance with one or more SNPs in 18 genes, including the two most replicated findings in the literature: DRD4 and DAT1. Gene-wide tests, adjusted for the number of SNPs analysed in each gene, identified associations with TPH2, ARRB2, SYP, DAT1, ADRB2, HES1, MAOA and PNMT. Further studies will be needed to confirm or refute the observed associations and their generalisability to other samples.


Subject(s)
Attention Deficit Disorder with Hyperactivity/genetics , Dopamine Plasma Membrane Transport Proteins/genetics , Genetic Predisposition to Disease/genetics , Receptors, Dopamine D4/genetics , Adolescent , Child , Child, Preschool , Genetic Markers/genetics , Haplotypes , Humans , Linkage Disequilibrium , Monoamine Oxidase/genetics , Oncogene Proteins/genetics , Pedigree , Polymorphism, Single Nucleotide/genetics , Receptors, Nicotinic/genetics , Siblings , Synaptosomal-Associated Protein 25/genetics , Tryptophan Hydroxylase/genetics
17.
Mol Psychiatry ; 10(9): 868-76, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15852063

ABSTRACT

The serotonin transporter gene (5-HTT) encodes a transmembrane protein that plays an important role in regulating serotonergic neurotransmission and related aspects of mood and behaviour. The short allele of a 44 bp insertion/deletion polymorphism (S-allele) within the promoter region of the 5-HTT gene (5-HTTLPR) confers lower transcriptional activity relative to the long allele (L-allele) and may act to modify the risk of serotonin-mediated outcomes such as anxiety and substance use behaviours. The purpose of this study was to determine whether (or not) 5-HTTLPR genotypes moderate known associations between attachment style and adolescent anxiety and alcohol use outcomes. Participants were drawn from an eight-wave study of the mental and behavioural health of a cohort of young Australians followed from 14 to 24 years of age (Victorian Adolescent Health Cohort Study, 1992 - present). No association was observed within low-risk attachment settings. However, within risk settings for heightened anxiety (ie, insecurely attached young people), the odds of persisting ruminative anxiety (worry) decreased with each additional copy of the S-allele (approximately 30% per allele: OR 0.77, 95% CI 0.62-0.97, P=0.029). Within risk settings for binge drinking (ie, securely attached young people), the odds of reporting persisting high-dose alcohol consumption (bingeing) decreased with each additional copy of the S-allele (approximately 35% per allele: OR 0.74, 95% CI 0.64-0.86, P<0.001). Our data suggest that the S-allele is likely to be important in psychosocial development, particularly in those settings that increase risk of anxiety and alcohol use problems.


Subject(s)
Alcohol Drinking/genetics , Anxiety/genetics , Membrane Glycoproteins/genetics , Membrane Transport Proteins/genetics , Nerve Tissue Proteins/genetics , Adolescent , Adult , Anxiety/physiopathology , Cohort Studies , Female , Follow-Up Studies , Genotype , Humans , Longitudinal Studies , Male , Psychology, Adolescent , Serotonin Plasma Membrane Transport Proteins , Sex Characteristics
18.
Mol Psychiatry ; 7(5): 493-502, 2002.
Article in English | MEDLINE | ID: mdl-12082567

ABSTRACT

The dopamine D(3) receptor gene (DRD3) is a candidate for a number of psychiatric conditions including schizophrenia, bipolar disorder and alcohol and drug abuse. Previous studies have reported associations between polymorphisms in DRD3 and these disorders, but these findings may have reflected linkage disequilibrium with pathogenic variants that are further upstream. We have isolated and sequenced approximately 9 kb of genomic sequence upstream of the human DRD3 translational start site. Using 5' RACE, we have identified within this region three additional exons and two putative promoter regions which show promoter activity in three different cell lines. A 5' UTR identified only in lymphoblasts is spread over three exons and is 353 bp long. A second 5' UTR, found in adult and fetal brain, lymphocytes, kidney and placenta is spread over two exons and is 516 bp long. A 260-bp sequence within this 9 kb corresponds to a previously reported EST, but corresponding mRNA could not be found in the tissues above. The EST, 5' UTRs and putative promoter regions have been analysed for polymorphisms, revealing 10 single nucleotide polymorphisms, seven of which were tested for association in a large sample of unrelated patients with schizophrenia and matched controls. No associations were observed with schizophrenia. In addition we failed to replicate previous findings of association with homozygosity of the Ser9Gly variant. The results from this study imply that neither the coding nor the regulatory region of DRD3 plays a major role in predisposition to schizophrenia.


Subject(s)
5' Untranslated Regions/genetics , Alternative Splicing/genetics , Mutation , Promoter Regions, Genetic , Receptors, Dopamine D2/genetics , Schizophrenia/genetics , Base Sequence , DNA Primers , Genotype , Humans , Molecular Sequence Data , Receptors, Dopamine D3
SELECTION OF CITATIONS
SEARCH DETAIL
...